{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-163400","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.949520+00:00","generated_at":"2026-05-18T03:19:14.864396+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Rein Therapeutics stockholders elect director Fairey, approve say-on-pay","bullets":["William C. Fairey elected as Class II director for three-year term expiring 2028; 7,661,847 for, 1,621,599 withheld.","Advisory vote on named executive officer compensation approved: 8,325,803 for, 146,938 against, 810,705 abstain.","Meeting held July 23, 2025, after being adjourned from June 24, 2025; no broker non-votes recorded."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-163400","json":"https://secwatch.observer/filing/0001193125-25-163400.json","markdown":"https://secwatch.observer/filing/0001193125-25-163400.md","text":"https://secwatch.observer/filing/0001193125-25-163400.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525163400/0001193125-25-163400-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525163400/d931384d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T03:19:14.864396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}